drugset / Trial / NCT01033565

Melatonin CR for the Treatment of Impaired Sleep Maintenance in 4-8 Year Old Children With Autism Spectrum Disorders

NCT01033565

Phase 4 Terminated 1 enrolled University of Nebraska
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research is to see the effects (good and bad) of Melatonin CR on sleep in 4-8 year old children with autism spectrum disorders and sleep problems.

Timeline

Start
2010-03-04
Primary completion
2010-10-01
Completion
2010-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Bismuth Potassium Citrate Unknown 5 mg

Indications